[go: up one dir, main page]

NO984697L - IL-6 mutein - Google Patents

IL-6 mutein

Info

Publication number
NO984697L
NO984697L NO984697A NO984697A NO984697L NO 984697 L NO984697 L NO 984697L NO 984697 A NO984697 A NO 984697A NO 984697 A NO984697 A NO 984697A NO 984697 L NO984697 L NO 984697L
Authority
NO
Norway
Prior art keywords
mutein
diseases
auotoimmune
plasmocytoma
neoplastic
Prior art date
Application number
NO984697A
Other languages
English (en)
Other versions
NO984697D0 (no
NO322479B1 (no
Inventor
Marc Ehlers
Stefan Rose-John
Joachim Grotzinger
Original Assignee
Applied Research Systems
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Applied Research Systems filed Critical Applied Research Systems
Publication of NO984697D0 publication Critical patent/NO984697D0/no
Publication of NO984697L publication Critical patent/NO984697L/no
Publication of NO322479B1 publication Critical patent/NO322479B1/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/54—Interleukins [IL]
    • C07K14/5412—IL-6
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Rheumatology (AREA)
  • Toxicology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Zoology (AREA)
  • Immunology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Compounds Of Unknown Constitution (AREA)
  • Details Of Television Scanning (AREA)
  • Diaphragms For Electromechanical Transducers (AREA)
  • Amplifiers (AREA)
NO19984697A 1996-04-09 1998-10-08 IL-6 mutein, fremgangsmate for fremstilling av muteinet, DNA-molekyl som koder for muteinet, samt vektor og vertscelle som inneholder DNA-molekylet og farmasoytisk blanding som omfatter muteinet. NO322479B1 (no)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
CN96180247A CN1131309C (zh) 1996-04-09 1996-04-09 白细胞介素－6突变蛋白
PCT/EP1996/001506 WO1997038103A1 (en) 1996-04-09 1996-04-09 Il-6 mutein
CA002251355A CA2251355C (en) 1996-04-09 1996-04-09 Il-6 mutein
PCT/EP1997/001736 WO1997038104A1 (en) 1996-04-09 1997-04-08 Il-6 mutein

Publications (3)

Publication Number Publication Date
NO984697D0 NO984697D0 (no) 1998-10-08
NO984697L true NO984697L (no) 1998-10-08
NO322479B1 NO322479B1 (no) 2006-10-09

Family

ID=27170853

Family Applications (1)

Application Number Title Priority Date Filing Date
NO19984697A NO322479B1 (no) 1996-04-09 1998-10-08 IL-6 mutein, fremgangsmate for fremstilling av muteinet, DNA-molekyl som koder for muteinet, samt vektor og vertscelle som inneholder DNA-molekylet og farmasoytisk blanding som omfatter muteinet.

Country Status (18)

Country Link
US (1) US6280975B1 (no)
EP (1) EP0907737B1 (no)
JP (1) JP4189866B2 (no)
CN (1) CN1131309C (no)
AT (1) ATE291087T1 (no)
AU (1) AU728267B2 (no)
BR (1) BR9708648B1 (no)
CA (1) CA2251355C (no)
DE (1) DE69634497T2 (no)
DK (1) DK0907737T3 (no)
EA (1) EA000852B1 (no)
ES (1) ES2238690T3 (no)
FI (1) FI982198A7 (no)
IL (1) IL126484A0 (no)
NO (1) NO322479B1 (no)
PT (1) PT907737E (no)
UA (1) UA72426C2 (no)
WO (2) WO1997038103A1 (no)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2299241T3 (es) 1998-03-17 2008-05-16 Chugai Seiyaku Kabushiki Kaisha Preventivos o remedios para enfermedades intestinales inflamatorias que contienen anticuerpos antagonistas del receptor il-6.
KR20060119412A (ko) * 2005-05-20 2006-11-24 아주대학교산학협력단 ＩＬ-6 발현 억제를 위한 ｓｉＲＮＡ 및 이를 함유하는조성물
US8522915B2 (en) * 2007-12-19 2013-09-03 Westerngeco L.L.C. Method and system for selecting parameters of a seismic source array
CN102101885B (zh) * 2010-09-01 2013-06-05 南京发士达生物科技有限公司 低诱导抑制性t细胞的人白细胞介素ⅱ突变体及其用途

Also Published As

Publication number Publication date
EA000852B1 (ru) 2000-06-26
EA199800914A1 (ru) 1999-04-29
CA2251355A1 (en) 1997-10-16
JP2000508164A (ja) 2000-07-04
AU5686496A (en) 1997-10-29
DE69634497D1 (de) 2005-04-21
FI982198L (fi) 1998-10-09
US6280975B1 (en) 2001-08-28
BR9708648B1 (pt) 2011-02-08
WO1997038103A1 (en) 1997-10-16
HK1019770A1 (en) 2000-02-25
FI982198A0 (fi) 1998-10-09
EP0907737B1 (en) 2005-03-16
NO984697D0 (no) 1998-10-08
WO1997038104A1 (en) 1997-10-16
IL126484A0 (en) 1999-08-17
ATE291087T1 (de) 2005-04-15
CA2251355C (en) 2009-06-09
NO322479B1 (no) 2006-10-09
DK0907737T3 (da) 2005-06-27
ES2238690T3 (es) 2005-09-01
EP0907737A1 (en) 1999-04-14
JP4189866B2 (ja) 2008-12-03
BR9708648A (pt) 1999-08-03
CN1216063A (zh) 1999-05-05
DE69634497T2 (de) 2006-01-26
CN1131309C (zh) 2003-12-17
AU728267B2 (en) 2001-01-04
UA72426C2 (en) 2005-03-15
PT907737E (pt) 2005-05-31
FI982198A7 (fi) 1998-10-09

Similar Documents

Publication Publication Date Title
BR9502707A (pt) Composto composição farmacêutica e método para o tratamento de uma afecção
MX9703546A (es) Benzotiazepinas hipolipidemicas.
PL358004A1 (en) Pteridine compounds for the treatment of psoriasis
EA200200806A1 (ru) Предупреждение потери и восстановление костной массы некоторыми агонистами простагландина
PL371428A1 (en) Substituted indolizine-like compounds and methods of use
UA42747C2 (uk) Похідні пептиду,фармацевтична композиція та спосіб стимулювання секреції гормону росту
DK1309589T3 (da) Ureaforbindelser og anvendelsesfremgangsmåder
BG66080B1 (bg) Заместени тиоацетамиди
SE9802729D0 (sv) Novel Compounds
DE60021381D1 (de) Chinonverbindungen zur behandlung von krankheiten
BR9708114A (pt) Análogos xantona para o tratamento de doenças infecciosas.
ATE158183T1 (de) Arzneimittel zur behandlung von anxietas
BR0211761A (pt) depsipeptìdeos e processos para preparar os mesmos
ATE289293T1 (de) Substituierte aminoalkylamid-derivate als antagonisten des follikel-stimulierenden hormons
ATE271861T1 (de) Verwendung von nmda-antagonisten und/oder natriumkanalantagonisten zur behandlung von entzündlichen erkrankungen
DE60129829D1 (de) Zyklisierte benzamid-neurokinin-antagonisten zur verwendung in therapie
DE69814109D1 (de) 1,3-dihydroxy-20,20-dialkyl-vitamin d3 analoga
DK0417003T3 (da) Anvendelse af antiprogestomimetiske forbindelser til fremme af ovulation
DK0907737T3 (da) IL-6-mutein
DE69819922D1 (de) 2-Amino-6-methyl-7-acetyl-tetralin und pharmazeutische Zusammensetzungen zur Vorbeugung und therapeutischen Behandlung von entzündlichen und/oder Autoimmunkrankheiten
BR0212249A (pt) Composto, composição farmacêutica, método de tratamento ou profilaxia de doenças, e, uso de um composto
PL328225A1 (en) Diphenylstilbenes as pro-medications used to produce cox-2-inhibitors
NO970573D0 (no) Ylidenforbindelser og deres fremstilling
ID24561A (id) Pemakaian protein matriks oligomerik kartilaj untuk mengobati artritis rematoid

Legal Events

Date Code Title Description
CREP Change of representative

Representative=s name: ONSAGERS AS, POSTBOKS 6963 ST OLAVS PLASS, 0130 OS

CREP Change of representative

Representative=s name: BRYN AARFLOT AS, POSTBOKS 443 SENTRUM, 0104 OSLO,

MM1K Lapsed by not paying the annual fees